Get the Stockscreener App
1.7801
1.72%
0.0301
Mira Pharmaceuticals Inc stock is traded at $1.7801, with a volume of 48,115.
It is up +1.72% in the last 24 hours and up +52.80% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.75
Open:
$1.742
24h Volume:
48,115
Relative Volume:
0.03
Market Cap:
$30.12M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-2.3376
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
-4.81%
1M Performance:
+52.80%
6M Performance:
+57.53%
1Y Performance:
-30.46%
1-Day Range:
$1.66
$1.80
1-Week Range:
$1.61
$2.09
52-Week Range:
$0.73
$3.73
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.7801 | 30.66M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
797.34 | 692.83B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
168.47 | 373.35B | 90.63B | 22.66B | 18.57B | 9.35 |
|
ABBV
Abbvie Inc
|
189.92 | 329.24B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
117.97 | 231.66B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
69.92 | 298.68B | 43.59B | 15.04B | 10.74B | 3.3766 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
MIRA Pharmaceuticals Inc. Stock Analysis and ForecastFree Stock Index Interpretation - Autocar Professional
What analysts say about MIRA Pharmaceuticals Inc. stockFree Market Dynamics Reports - Autocar Professional
Is MIRA Pharmaceuticals Inc. a good long term investmentFree Risk Assessment Services - jammulinksnews.com
What drives MIRA Pharmaceuticals Inc. stock priceRapid-fire capital growth - Autocar Professional
why mira pharmaceuticals inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser
Will MIRA Pharmaceuticals Inc. stock split in the near futureTop ROI Selections - Newser
How MIRA Pharmaceuticals Inc. stock performs during market volatilityShort Term Risk Controlled Alerts - Newser
Why MIRA Pharmaceuticals Inc. stock attracts strong analyst attentionInvestor Favorite Picks - Newser
What makes MIRA Pharmaceuticals Inc. stock price move sharplyFree Expert Investment Advice - Newser
MIRA Stocks Surge: Are They Viable Investments? - StocksToTrade
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
MIRA Pharmaceuticals Raises $2M Through Stock Sale - TipRanks
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition - Pocono Record
Mira Says Preclinical Results of Obesity, Nicotine Addiction Treatment Drug Show Reversal of Anxiety-Like Behavior - MarketScreener
MIRA’s obesity drug candidate shows anti-anxiety effects in study By Investing.com - Investing.com India
Mira Pharmaceuticals reports preclinical data on SKNY-1 candidate - TipRanks
MIRA’s obesity drug candidate shows anti-anxiety effects in study - Investing.com
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mira Pharmaceuticals Inc Stock (MIRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aminov Erez | Chief Executive Officer |
Nov 20 '24 |
Sale |
1.27 |
44,590 |
56,629 |
1,061,200 |
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):